ArticleFrontiers in cellular and infection microbiology2026
Sex-specific signatures of gut microbiota and systemic inflammation in patients with urolithiasis: a cross-sectional study.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urolithiasis is a globally prevalent disease with a distinct male predominance; however, the pathophysiological heterogeneity within diagnosed cohorts remains underexplored. This study delineates the sex-specific signatures of gut microbiota and systemic inflammation in urolithiasis patients to inform sex-stratified management. Methods: This cross-sectional study enrolled 60 urolithiasis patients (40 males, 20 females). Systemic inflammatory cytokines were quantified via peripheral blood assays, and gut microbiota was profiled using 16S rRNA sequencing. Data were integrated to evaluate microbiome-immune-metabolic associations. Results: Baseline demographics and routine biochemical parameters were comparable between sexes. Male patients exhibited significantly elevated peripheral levels of pro-inflammatory cytokines, including IL-5, IL-17A, IFN-α, IL-12P70, and IFN-γ (P < 0.05). Beta-diversity analysis revealed no significant difference in the overall gut microbial community structures between sexes (P = 0.484). LEfSe analysis identified a significant enrichment of Conclusion: Our findings highlight significant sex-associated differences in gut microecology and systemic immune profiles within urolithiasis patients. The proinflammatory axis associated with male patients and the enhanced predicted metabolic capacities observed in female patients emphasize the potential value of exploring sex-tailored preventive and therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.